XBiotech Inc.XBITNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, above historical average, modest growth trend.
Left:
||||
Year-over-year net income growth rate
Latest
-242.14%
↑ 75% above average
Average (39q)
-955.39%
Historical baseline
Range
High:11262.52%
Low:-48785.71%
CAGR
+8.3%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | -242.14% |
| Q2 2025 | 83.87% |
| Q1 2025 | -3.58% |
| Q4 2024 | -109.53% |
| Q3 2024 | 61.44% |
| Q2 2024 | -30.03% |
| Q1 2024 | -115.79% |
| Q4 2023 | 37.06% |
| Q3 2023 | 15.76% |
| Q2 2023 | -129.09% |
| Q1 2023 | -19.14% |
| Q4 2022 | 74.70% |
| Q3 2022 | -8.71% |
| Q2 2022 | -115.83% |
| Q1 2022 | 16.58% |
| Q4 2021 | -98.31% |
| Q3 2021 | 36.28% |
| Q2 2021 | -99.30% |
| Q1 2021 | -39.72% |
| Q4 2020 | 27.24% |
| Q3 2020 | 63.09% |
| Q2 2020 | -48785.71% |
| Q1 2020 | -100.00% |
| Q4 2019 | 11262.52% |
| Q3 2019 | -5.09% |
| Q2 2019 | 0.20% |
| Q1 2019 | 4.04% |
| Q4 2018 | -20.99% |
| Q3 2018 | 14.49% |
| Q2 2018 | -45.17% |
| Q1 2018 | 43.87% |
| Q4 2017 | -16.83% |
| Q4 2017 | 32.06% |
| Q2 2017 | 13.54% |
| Q1 2017 | 35.58% |
| Q4 2016 | -31.35% |
| Q3 2016 | 8.35% |
| Q2 2016 | -32.81% |
| Q1 2016 | 13.73% |
| Q4 2015 | -10.74% |